Schizophrenia is a heritable complex phenotype associated with a background risk
involving multiple common genetic variants of small effect and a multitude of environmental …

Schizophrenia is a devastating illness that affects up to 1% of the population; it is characterized
by a combination of positive symptoms, negative symptoms, and cognitive impairment. …

Preclinical Research After the identification of the schizophrenia as an illness over a century
ago, treatment of affected individuals included unspecific, mostly very robust methods …

Increased reactivity to stress is observed in patients with schizophrenia spectrum disorders
and their healthy siblings in comparison with the general population. Additionally, higher …

Hypothalamic–pituitary–adrenal (HPA) axis activity mediates the relationship between
childhood trauma (CT) and psychosis. The FKBP5 gene, one of the key regulators of HPA axis …

Objective: Certain copy number variants (CNVs) greatly increase the risk of autism. The
authors conducted a genetics-first study to investigate whether heterogeneity in the clinical …

Exposures constitute a dense network of the environment: exposome. Here, we argue for
embracing the exposome paradigm to investigate the sum of nongenetic “risk” and show how …

Seismic surveys are conducted worldwide to explore for oil and gas deposits and to map
subsea formations. The airguns used in these surveys emit low-frequency sound waves. …

“Druggable genome” is a novel concept that emphasizes the importance of using the
information of genome-wide genetic studies for drug discovery and development. Successful …

Abstract Treatment resistant (TR) psychosis is considered to be a significant cause of
disability and functional impairment. Numerous efforts have been made to identify the clinical …